Hi Daniel, thanks for the expansion on this. To clarify, are we at this stage going to delineate between ‘increasing m6a levels’ and ‘inhibiting FTO/decreasing FTO levels’? Is this a functionally important distinction, or will any P1A/B lead in data around FTO inhibition be synonymous with increased m6a?
Hi Daniel, thanks for the expansion on this. To clarify, are we...
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
-0.095(5.44%) |
Mkt cap ! $285.2M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.78 | $1.62 | $221.4K | 131.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 61 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.66 | 1000 | 1 |
View Market Depth
| Last trade - 15.24pm 03/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |